Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure
- 7 July 2008
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 156 (3) , 437-444
- https://doi.org/10.1016/j.ahj.2008.05.003
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery DiseaseJAMA, 2007
- An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial)American Heart Journal, 1999
- Major depression in hospitalized medically ill older men: Documentation, management, and outcomeInternational Journal of Geriatric Psychiatry, 1992
- Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS)The American Journal of Cardiology, 1990
- Predictors of total mortality and sudden death in mild to moderate heart failureJournal of the American College of Cardiology, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Arrhythmias, catecholamines and electrolytesThe American Journal of Cardiology, 1988
- Prognosis of congestive heart failure and predictors of mortalityThe American Journal of Cardiology, 1988
- Quality of life post-myocardial infarction: Effects of a transtelephonic coronary intervention system.Health Psychology, 1988
- Correlates and prognostic implication of exercise capacity in chronic congestive heart failureThe American Journal of Cardiology, 1985